These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15078730)

  • 41. Expression of human T lymphotropic virus type 1 (HTLV-1) tax/rex gene in fresh bronchoalveolar lavage cells of HTLV-1-infected individuals.
    Higashiyama Y; Katamine S; Kohno S; Mukae H; Hino S; Miyamoto T; Hara K
    Clin Exp Immunol; 1994 May; 96(2):193-201. PubMed ID: 7910532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deterioration of asthma in a patient with diffuse panbronchiolitis (DPB) after macrolide therapy.
    Matsuno O; Ueno K; Hayama Y; Honda H; Yamane H; Saeki Y
    J Asthma; 2010 May; 47(4):486-8. PubMed ID: 20528606
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [HABA (HTLV-I associated bronchiolo-alveolar disorder)].
    Kimura I
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):787-95. PubMed ID: 1630042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single center experience of five diffuse panbronchiolitis patients clinically presenting as severe asthma.
    Park KH; Park HJ; Lee JH; Park JW
    J Korean Med Sci; 2015 Jun; 30(6):823-8. PubMed ID: 26028938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Analysis of cases allowed to cease erythromycin therapy for diffuse panbronchiolitis--comparative study between patients with cessation of the therapy and patients continuing the therapy].
    Shirai R; Abe K; Yoshinaga M; Ishimatsu Y; Matsubara Y; Kawakami K; Iida K; Fujii T; Kawamoto S; Kaseda M; Kadota J; Kohno S
    Kansenshogaku Zasshi; 1997 Nov; 71(11):1155-61. PubMed ID: 9455056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A study of bronchoalveolar lavage analysis in patients with diffuse panbronchiolitis--the results of low dose and long term erythromycin treatment].
    Mukae H; Sakito O; Oda H; Senju R; Hiratani K; Kadota J; Fukushima K; Komori K; Kouno S; Hara K
    Kansenshogaku Zasshi; 1991 Jun; 65(6):692-7. PubMed ID: 1919099
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Expression of IL-2 receptor in peripheral blood lymphocytes and bronchoalveolar lavage fluid (BAL) in patients with sarcoidosis].
    Koktysz M; Kieszko R; Dmoszyńska A; Milanowski J; Roliński J
    Pol Arch Med Wewn; 1998 Jan; 99(1):9-14. PubMed ID: 9686498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High levels of soluble interleukin 2 receptors released from human retrovirus-infected cells.
    Honda M; Yamamoto N; Nagao S; Tokunaga T
    Jpn J Cancer Res; 1987 Sep; 78(9):889-93. PubMed ID: 2889714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated levels of beta-chemokines in bronchoalveolar lavage fluid (BALF) of individuals infected with human T lymphotropic virus type-1 (HTLV-1).
    Seki M; Kadota JI; Higashiyama Y; Iida K; Iwashita T; Sasaki E; Maesaki S; Tomono K; Kohno S
    Clin Exp Immunol; 1999 Dec; 118(3):417-22. PubMed ID: 10594561
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significance of IL-1beta and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB).
    Kadota J; Matsubara Y; Ishimatsu Y; Ashida M; Abe K; Shirai R; Iida K; Kawakami K; Taniguchi H; Fujii T; Kaseda M; Kawamoto S; Kohno S
    Clin Exp Immunol; 1996 Mar; 103(3):461-6. PubMed ID: 8608647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bronchoalveolar lymphocytosis in patients with tropical spastic paraparesis associated with human T-cell lymphotropic virus type 1 (HTLV-1). Clinical, immunologic, and cytologic studies.
    Couderc LJ; Caubarrere I; Venet A; Magdeleine J; Jouanelle A; Danon F; Buisson G; Vernant JC
    Ann Intern Med; 1988 Oct; 109(8):625-8. PubMed ID: 2901817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Altered expression of inflammatory cytokines in primary osteoarthritis by human T lymphotropic virus type I retrovirus infection: a cross-sectional study.
    Yoshihara Y; Tsukazaki T; Osaki M; Nakashima M; Hasui K; Shindo H
    Arthritis Res Ther; 2004; 6(4):R347-54. PubMed ID: 15225370
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diffuse panbronchiolitis in rheumatoid arthritis.
    Homma S; Kawabata M; Kishi K; Tsuboi E; Narui K; Nakatani T; Uekusa T; Saiki S; Nakata K
    Eur Respir J; 1998 Aug; 12(2):444-52. PubMed ID: 9727799
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diffuse panbronchiolitis--a case report.
    Poh SC; Wang YT; Wang WY
    Singapore Med J; 2001 Jun; 42(6):271-4. PubMed ID: 11547966
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infection of human T lymphotropic virus-I-specific immune T cell clones by human T lymphotropic virus-I.
    Mitsuya H; Jarrett RF; Cossman J; Cohen OJ; Kao CS; Guo HG; Reitz MS; Broder S
    J Clin Invest; 1986 Nov; 78(5):1302-10. PubMed ID: 2877011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Three cases of chronic respiratory tract lesions associated with adult T-cell leukemia (ATL)].
    Taguchi H; Takaoka K; Nasuhara Y; Kawakami Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30(12):2134-8. PubMed ID: 1289635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Bronchoalveolar lavage in diffuse panbronchiolitis].
    Ichikawa Y; Koga H; Nakamua M; Tanaka M; Tokunaga N; Kaji M
    Kansenshogaku Zasshi; 1989 Dec; 63(12):1350-1. PubMed ID: 2621388
    [No Abstract]   [Full Text] [Related]  

  • 58. High concentrations of beta-chemokines in BAL fluid of patients with diffuse panbronchiolitis.
    Kadota J; Mukae H; Tomono K; Kohno S
    Chest; 2001 Aug; 120(2):602-7. PubMed ID: 11502665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diffuse panbronchiolitis.
    Poletti V; Chilosi M; Casoni G; Colby TV
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):94-104. PubMed ID: 15281430
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery and significance of new human T-lymphotropic viruses: HTLV-3 and HTLV-4.
    Bagossi P; Bander P; Bozóki B; Tözsér J
    Expert Rev Anti Infect Ther; 2009 Dec; 7(10):1235-49. PubMed ID: 19968515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.